Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis

Condition:   Recurrent Respiratory PapillomatosisInterventions:   Drug: Bevacizumab;   Drug: Cidofovir;   Other: PlaceboSponsor:   Centro de Investigación en. Enfermedades Infecciosas, MexicoRecruiting - verified September 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials